Reprise Biomedical
Reprise Biomedical, Inc.
Reprise Biomedical, Inc. is a medical biotechnology company that develops and commercializes biologic medical devices for the healthcare industry. Spun off from Miromatrix Medical in 2019, the company focuses on advanced wound care and soft tissue reinforcement solutions. It leverages a proprietary perfusion decellularization technology to create biologic scaffolds that promote healing and cellular integration.
Products & Team
Miro3D® Wound Matrix
Miro3D® is a three-dimensional, 2cm thick acellular graft derived from porcine tissue using the company's proprietary technology. It is specifically designed to manage complex wounds, including those that are deep, tunneling, or have irregular geometries, providing a robust scaffold for cellular infiltration and tissue regeneration.
It addresses the clinical challenge of treating deep and tunneling wounds, which are difficult to manage with conventional flat matrices, by providing a thick, conformable scaffold that promotes rapid cellular integration and healing.
The company's products address the clinical difficulty of effectively treating complex wounds like diabetic foot ulcers, pressure ulcers, and especially deep or tunneling wounds that do not respond to standard care. It also provides a solution for surgeons seeking durable, biologic options for soft tissue reinforcement in procedures such as hernia repair.